Scientists from the Georgia Institute of Technology have developed polymeric microparticles that could be loaded with therapeutic bacteriophages, and delivered to the lungs via inhalation. Treatment with the phages protected both regular mice and mouse models of cystic fibrosis from otherwise lethal infections with Pseudomonas aeruginosa.